Quantcast

Latest carvedilol Stories

2013-10-24 23:04:58

Reportbuyer.com just published a new market research report: PharmaPoint: Chronic Heart Failure - United Kingdom Drug Forecast and Market Analysis to 2022. London (PRWEB) October 24, 2013 PharmaPoint: Chronic Heart Failure - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - United Kingdom Drug Forecast and Market Analysis to 2022”. The chronic heart failure (CHF) market is a mature...

2013-10-23 23:20:53

Reportbuyer.com just published a new market research report: PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022. London (PRWEB) October 23, 2013 PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022”. The chronic heart failure (CHF) market is a mature market that has been slowly overtaken...

2012-05-14 10:00:48

A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk. In recent years, researchers have thought that beta blockers, which are prescribed to many older adults...

2010-06-24 14:29:26

Drugs may promote memory function and reduce cognitive deterioration without influencing blood pressure Researchers at Mount Sinai School of Medicine have found that the drug carvedilol, currently prescribed for the treatment of hypertension, may lessen the degenerative impact of Alzheimer's disease and promote healthy memory functions. The new findings are published in two studies in the current issues of Neurobiology of Aging and the Journal of Alzheimer's Disease. "These studies are...

2009-11-20 15:46:45

In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity. The study, which appears in the journal Circulation Research, found that beta-blockers that target both the alpha- and beta-receptors on the heart muscle offer the most benefit to cardiac patients, while those that target only the beta-receptors can actually undermine the structure and function of the heart....

2009-11-17 07:00:00

Study highlights: -- Although many studies have shown that beta blockers improve outcomes for heart failure patients, the optimum dose is still unknown. -- A new Japanese study finds the smallest dose of beta blockers is as effective as larger ones, with fewer side effects. ORLANDO, Fla., Nov. 17 /PRNewswire-USNewswire/ -- Tailoring the dose of a heart failure drug to a patient's response is better than the one-size-fits-all approach, according to research presented in a late-breaking...

2009-08-19 09:54:33

Patients with cirrhosis are at risk for developing portal hypertension that can lead to the formation, dilation, and rupture of esophageal varices. The annual incidence of esophageal varices is approximately 5% and one third of those will bleed.In a recent study, researchers from the University of Edinburgh determined carvedilol was more effective in the prevention of variceal hemorrhaging than variceal band ligation (VBL), a common treatment used for the past 20 years. The results of the...

2008-08-01 12:01:08

BROOMFIELD, Colo., Aug. 1 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced today that it has appointed James Carr, PharmD, as vice president of marketing. In this newly created position, Mr. Carr will define and execute marketing programs to support the company's lead product candidate, Gencaro(TM) (bucindolol hydrochloride), a pharmacologically unique beta-blocker and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.